Mankai Ju

Statistics

Publications

Citations

199

H-Index

Active since

2018

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

Institute of Hematology & Blood Diseases Hospital

Tianjin Medical University

Peking Union Medical College Hospital

Second Hospital of Tianjin Medical University

Mankai Ju is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in hematology, life sciences, and jak2 v617f mutation.

ORCID

Publications per year

2018–2024

Publications

Hematopoietic Stem Cell Heterogeneity Is Linked to the Initiation and Therapeutic Response of Myeloproliferative Neoplasms

Jingyuan Tong, Ting Sun, Shihui Ma et al. · Cell stem cell · 2021 · 61 citations · Full text

Life Sciences, Cell Biology, Hematology +17

A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia

Yunfei Chen, Yanmei Xu, Huiyuan Li et al. · New England Journal of Medicine · 2024 · 47 citations

Life Sciences, Hematology, Immunology +15

Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I trial

Yunfei Chen, Yanmei Xu, Ying Chi et al. · Signal Transduction and Targeted Therapy · 2024 · 33 citations · Full text

Life Sciences, Hematology, Immunology +14

Prediction of thrombosis in polycythemia vera: Development and validation of a multiple factor-based prognostic score system

Wenjing Gu, Yuhui Zhang, Ting Sun et al. · Research and Practice in Thrombosis and Haemostasis · 2023 · 16 citations · Full text

Medicine, Biostatistics, Hematology +17

Single‐dose rituximab plus glucocorticoid versus cyclophosphamide plus glucocorticoid in patients with newly diagnosed acquired hemophilia A: A multicenter, open‐label, randomized noninferiority trial

Panjing Wang, Rongfu Zhou, Feng Xue et al. · American Journal of Hematology · 2023 · 16 citations · Full text

Pharmacy, Hematology, Pharmacotherapy +9

1–5 of 7